The KCNK18 gene gives instructions for a channel in pain related nerve cells that helps keep them from firing too easily. This gene helps your body control pain signals, especially in nerves linked to headaches and facial pain. If the gene does not work well, these nerves may become more excitable, which can raise the chance of migraine in some people. Rare variants in the KCNK18 gene have been studied most in people with migraine, but they do not explain most migraine cases.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes contain the directions for building proteins, the parts that do much of the cell’s work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic further, you can read more in the LearnHub.
Overview
KCNK18Gene function
What if the gene works
The KCNK18 gene helps make a protein in nerve cells that helps calm electrical activity. This helps control how easily pain sensing nerves, especially in the face and head, send signals.
Risk
What if the gene does not work
Milder to more severe variants in the KCNK18 gene can partly or fully reduce TRESK channel activity, a tiny pore that helps control nerve-cell electrical signals. This may weaken how certain sensory nerve cells stay electrically stable.
Treatment
What does that mean for your treatment
At present, no treatment or drug choice is guided specifically by pathogenic variants in the KCNK18 gene in routine clinical guidelines. Researchers are studying the KCNK18 gene as a possible pain and migraine drug target through its TRESK channel.
Gene function
What if the gene works
Many of your sensory nerves need brief pauses between messages so they do not fire too easily. The KCNK18 gene helps provide that steadying effect by supporting a potassium channel in nerve cells. Understanding how the KCNK18 gene works in nerve cells helps explain how normal electrical signaling stays balanced.
The KCNK18 gene helps make a channel that lets potassium move out of nerve cells at a steady, low level. This constant flow helps create the normal electrical conditions cells need at rest.
In sensory nerves, this channel helps keep the cell's resting charge stable between signals. That steady baseline makes nerve activity more controlled in everyday cell function.
After a nerve cell sends a message, potassium movement through this channel helps it settle back toward its usual state. This supports smoother repeat signaling when nerves are active.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KCNK18 gene can change the shape or stability of its potassium channel, so the channel may open less well, carry less potassium, or fail to reach the cell surface. This is how KCNK18 variants affect potassium channel function at the cell level. Milder variants may only partly reduce channel current, while more severe variants can leave the channel largely inactive or truncated, which can strengthen the functional impact.
How variants are linked to conditions
At this point, how KCNK18 gene variants are linked to conditions is still being worked out, and the KCNK18 gene does not yet have a broadly confirmed link to one specific health condition. If you have a reported change in the KCNK18 gene, your doctor or genetic counselor can explain what that result means in the context of your own symptoms and family history.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences contribute. Still, in some situations, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce risk related to the KCNK18 gene. In families with a gene change, migraine symptoms can still vary a lot from one person to another, which suggests other genes and everyday factors also play a part. Anyone concerned about personal risk can talk with a doctor or genetic counselor.
Inheritance of KCNK18 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the inheritance of the KCNK18 gene variants, even though some families with migraine have been studied for changes in this gene. Current evidence does not support presenting KCNK18 as having one clearly established dominant or recessive pattern for a specific condition. The KCNK18 gene is located on chromosome 10, which is an autosome, so you inherit one copy from each parent. That means any gene change in KCNK18 can be passed through either side of the family.
What does my KCNK18 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for KCNK18, and research on this gene is still developing. If you have a KCNK18 result, what it could mean for relatives depends a lot on the exact change found and why testing was done. A doctor or genetic counselor can help explain whether family members might also want to review the result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for KCNK18 variants usually uses a blood or saliva sample to read the DNA sequence of the KCNK18 gene. Results may show no variant, a benign variant, or a variant that may help explain symptoms. Sometimes the gene is checked as part of a broader headache or migraine panel.
When should I consider getting a genetic test?
There is not yet a broadly established, KCNK18-specific reason to get genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your symptoms and family history, especially if migraine runs in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and on the kind of variant identified. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may help less in another person, or may cause more side effects, because the body can absorb, break down, transport, or respond to the medicine differently. These inherited differences are common and are one reason medication response is not the same for everyone. In practice, this can influence how well a treatment works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect response to medications. It looks at links between genes and drugs to help explain why treatment effects can differ from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the KCNK18 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about new symptoms, side effects, or changes in how a medicine feels are best discussed with your doctor.
History
KCNK18 entered the genetics literature in the early 2000s during efforts to map a growing family of potassium channel genes. Interest in this gene increased after researchers linked a variant in KCNK18 to migraine with aura in a large family, bringing it into headache genetics research. From these first observations, research expanded steadily, and follow-up studies explored whether other KCNK18 variants might contribute to migraine in different groups. That work also showed a more complicated picture, with some findings not repeating consistently across studies. Over time, scientists came to view KCNK18 as a gene of interest in migraine biology rather than a single answer for most people with migraine. Its history reflects a common pattern in genetics, where an early discovery opens the door and later studies refine the story.